ASTERDM

May 20 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• Q4 CONSOL NET PROFIT 790.2 MILLION RUPEES

• Q4 CONSOL REVENUE FROM OPERATIONS 10 BILLION RUPEES

• DIVIDEND 1 RUPEE PER SHARE

Further company coverage: ATRD.NS

(([email protected];;))

April 18 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• ASTER DM HEALTHCARE - CCI APPROVES MERGER BETWEEN CO, QUALITY CARE INDIA

• ASTER DM HEALTHCARE - MERGED ENTITY EXPECTED TO GROW TO ABOUT 13,300 BEDS BY FY27

• ASTER DM HEALTHCARE LTD - MERGER TRANSACTION EXPECTED TO BE COMPLETED THIS YEAR

Source text: ID:nBSE1TYzPs

Further company coverage: ATRD.NS

(([email protected];))

April 15 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• INDIA COMPETITION REGULATOR: APPROVES TRANSACTION INVOLVING ASTER DM HEALTHCARE, BCP ASIA, CENTELLA AND QUALITY CARE INDIA

Further company coverage: ATRD.NS

(([email protected];))

March 20 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• GETS ORDER DEMANDS TAX AMOUNT OF 10.8 MILLION RUPEES AND PENALTY

Source text: ID:nBSE56DwfX

Further company coverage: ATRD.NS

(([email protected];;))

Jan 31 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• Q3 CONSOL NET PROFIT 567.9 MILLION RUPEES; IBES PROFIT EST. 927.8 MILLION RUPEES

• Q3 CONSOL REVENUE FROM OPERATIONS 10.5 BILLION RUPEES; IBES EST. 10.74 BILLION RUPEES

• DIVIDEND OF 4 RUPEES PER SHR

Source text: ID:nBSE128mFC

Further company coverage: ATRD.NS

(([email protected];;))

Dec 12 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• INVESTS USD 4.9 MILLION IN AFFINITY

Source text: ID:nBSE67z1vv

Further company coverage: ATRD.NS

(([email protected];;))

** Shares of Aster DM Healthcare ATRD.NS rise as much as 4.9% to record high of 524.7 rupees, set to extend gains to seventh straight session

** Healthcare services provider announces merger with Quality Care India, with Aster holding 57.3% stake in merged entity

** Merged entity expects addition of ~3,500 new beds between FY24-27

** Analysts at Centrum are positive on the deal as the merged entity will have dominant presence in central and south India, allowing it to "potentially gain patient volumes and ward off competition"

** Avg rating of eight analysts covering the stock is "buy" and median PT is 555 rupees, ~8% higher than current price - LSEG data

** ATRD last up 3%, extending YTD gains to ~63%

(Reporting by Anuran Sadhu in Bengaluru)

(([email protected]; +91 8697274436;))

Nov 29 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• ASTER AND BLACKSTONE-BACKED QUALITY CARE TO MERGE AND CREATE ONE OF THE TOP 3 HOSPITAL CHAINS IN INDIA

• CO AND QUALITY CARE INDIA TO MERGE

• MERGED ENTITY TO BE NAMED ASTER DM QUALITY CARE LIMITED

• MERGED ENTITY WILL BE JOINTLY CONTROLLED BY ASTER PROMOTERS AND BLACKSTONE, HOLDING 24.0% AND 30.7% OWNERSHIP RESPECTIVELY

• MERGER TRANSACTION EXPECTED TO CLOSE BY Q3 FY26

• ASTER SHAREHOLDERS WILL HOLD 57.3%

• COMBINED ENTITY TO HAVE 38 HOSPITALS AND 10,150+ BEDS

• QCIL SHAREHOLDERS WILL HOLD 42.7% IN MERGED ENTITY

• VARUN KHANNA, GROUP MD OF QUALITY CARE, WILL BE MD AND GROUP CEO OF MERGED ENTITY

Further company coverage: ATRD.NS

(([email protected];;))

** Aster DM Healthcare ATRD.NS rises 5.1% to 462.30 rupees; set to gain for fourth straight session

** Hospital operator enters into agreement to buy remaining 13% stake in subsidiary Prerana Hospital for an amount to be determined by independent valuation report

** Prerana Hospital, which posted 1.21 bln-rupee ($14.3 mln) turnover in FY24, operates 254-bed multi-speciality hospital in Maharashtra's Kolhapur

** Around 4.8 mln shares traded, 2.8x the 30-day avg

** ATRD up ~46% YTD

($1 = 84.4530 Indian rupees)

(Reporting by Vijay Malkar)

(([email protected];))

Nov 26 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• ENTERS AGREEMENT TO ACQUIRE ADDITIONAL 13% OF PRERANA HOSPITAL

Source text: ID:nBSE7dHT6d

Further company coverage: ATRD.NS

(([email protected];))

** Global Health GLOH.NS rises 4% to 1,073.75 rupees

** Hospitals operator's Q2 consol profit up 4.5% y/y; rev grows 12.5%

** Larger rivals Apollo Hospitals Enterprise APLH.NS and Aster DM Healthcare ATRD.NS log strong Q2 results on higher occupancy

** Stock set to end week in the green, after last week's decline

** GLOH up ~11% YTD

(Reporting by Vijay Malkar)

(([email protected];))

** Shares of hospital chain Aster DM Healthcare Ltd ATRD.NS jump as much as 13.9% to record 457.90 rupees

** ATRD reports profit in Q2, compared to year ago loss when its erstwhile gulf business reported a loss

** ATRD's revenue rose 16%, helped by improvement in occupancy

** Over 6.4 mln shares traded, 8.6x the 30-day avg volume

** Five analysts tracking ATRD rate it "buy" on avg, same as larger rivals Apollo Hospitals APLH.NS and Max Healthcare MAXE.NS - LSEG data

** ATRD's 43% YTD jump leads pack; MAXE rises ~32%, while APLO up just 7%

(Reporting by Nandan Mandayam in Bengaluru)

(([email protected]; Mobile: +91 9591011727;))

Aug 5 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• CEO NITISH SHETTY RESIGNS

Source text for Eikon: ID:nNSE8pFvjW

Further company coverage: ATRD.NS

(([email protected];))

** Shares of hospital chain Aster DM Healthcare ATRD.NS rise 5.3% to 365 rupees

** Co on Wednesday reported 81% surge in Q1 profit, on higher bed occupancy rates

** ATRD up 17% YTD; Fortis Healthcare FOHE.NS rises 20%, Indraprastha Medical Corp IMCL.NS surges 55%, Max Healthcare MAXE.NS climbs 34%, Apollo Hospitals APLH.NS rises 16%

** ATRD, FOHE, MAXE & APLH "buy" rated on avg; IMCL not rated - LSEG

(Reporting by Sethuraman NR in Bengaluru)

(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))

July 19 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• MALABAR INSTITUTE OF MEDICAL SCIENCES TO ACQUIRE 25% STAKE IN USOLAR ASSETCO

• COST OF ACQUISITION 78.8 MILLION RUPEES

Source text for Eikon: ID:nBSED6jFt

Further company coverage: ATRD.NS

(([email protected];))

** Shares of Aster DM Healthcare Ltd ATRD.NS up 4.1%

** Morgan Stanley and Government of Singapore pick up combined ~1.9% stake in hospitals operator on Friday after Olympus Capital's block sale - BSE data

** Around 2.4 mln shares traded vs 30-day avg of 1.9 mln shares

** All six analysts tracking ATRD rate it "buy" or higher; median PT is 402.50 rupees - LSEG data

** ATRD's 21.2% YTD rise better than bigger rivals Fortis FOHE.NS and Apollo APLH.NS, but trails likes of Max Healthcare MAXE.NS and Global Health GLOH.NS

(Reporting by Nandan Mandayam in Bengaluru)

(([email protected]; Mobile: +91 9591011727;))

** Shares of Aster DM Healthcare ATRD.NS up 1.1% at 360.30 rupees after rising as much as 3.5%

** Over 1.8 mln shares traded in five blocks at 342-351.30 rupees/share - LSEG data

** Stock is witnessing its most active trading session since April 15, with more than 12.5 mln shares changing hands, 11x of 30-day avg

** Avg rating of six analysts equivalent of "strong buy", median PT is 402.50 rupees - LSEG data

** Stock up 14.2% so far this quarter vs 0.1% fall in March quarter

(Reporting by Ashish Chandra in Bengaluru)

(([email protected] (+91 7982114624))

** Shares of India's Aster DM Healthcare ATRD.NS down 2.2% after a 7.5% drop earlier in the day

** ATRD set to snap four session gaining run, if trend holds

** Co reported Q4 consol net loss vs profit yr ago, rev rose ~21%

** YTD stock has jumped 17% after a 77% climb in 2023, which was its fourth straight year of rise

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

April 25 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• AMITABH JOHRI WILL BE RELIEVED FROM SERVICES OF JOINT CFO

• SUNIL KUMAR M R, CURRENTLY JOINT CFO, WILL ASSUME ROLE OF CFO

Source text for Eikon: ID:nBSE4V65RT

Further company coverage: ATRD.NS

(([email protected];))

** Shares of Aster DM Healthcare ATRD.NS up as much as 14.3% to a record high of 558 rupees

** The healthcare services provider on Friday declared a special dividend of 118 rupees per share

** This comes after receiving proceeds from the sale of the GCC business and redemption of redeemable preference shares issued by its unit Affinity Holdings

** Stock on track for a third consecutive session of gains, if trend holds

** Average rating of five analysts covering the stock is "strong buy"; median PT is 480 rupees - LSEG data

** Including session's gain, stock is up 30.8% this year, outpacing the 5.1% rise in the Nifty 500 index .NIFTY500

(Reporting by Navamya Ganesh Acharya in Bengaluru)

(([email protected]; +91 8805175330 ;))

April 12 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• ASTER DM HEALTHCARE LTD - DECIDED NOT TO DECLARE AN INTERIM DIVIDEND FOR FINANCIAL YEAR 2023-24

• ASTER DM HEALTHCARE - SPECIAL DIVIDEND 118 RUPEES PER SHARE

Source text for Eikon: ID:nNSE52Fwhs

Further company coverage: ATRD.NS

(([email protected];))

** Shares of Aster DM Healthcare ATRD.NS up 5.9%, trimming some gains after rising as much as 9.5% to a record high of 500 rupees

** Reuters could not immediately ascertain a reason for stock move

** The healthcare services provider said it will consider declaration of special dividend on April 12

** Stock gained 11.6% last week, highest weekly gains since December, after co announced expansion plans worth 10 bln rupees ($120.1 mln)

** Around 3.1 mln shares traded, 2.8x the 30-day avg

** Analysts' avg rating on co is "Buy", their median PT is 480 rupees - a 5% premium on last close - LSEG

** Including session's gains, stock up ~18% YTD, peer Apollo Hospitals APLH.NS gained 10.6%

($1 = 83.2850 Indian rupees)

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

April 5 (Reuters) - MASHREQBANK MASB.DU:

• A CONSORTIUM OF INVESTORS LED BY FAJR CAPITAL ALONGSIDE DR. MOOPEN FAMILY COMPLETED 100% ACQUISITION OF ASTER’S GCC BUSINESS

• ACQUISITION OF ASTER’S GCC BUSINESS IS NOW OWNED 65% BY FAJR CAPITAL-LED CONSORTIUM WITH A 35% STAKE RETAINED BY DR. MOOPEN FAMILY

• IN NEWLY SEPARATED ASTER GCC, DR. AZAD MOOPEN WILL BE CONTINUING IN HIS ROLE AS FOUNDER & CHAIRMAN

• IN NEWLY SEPARATED ASTER GCC, ALISHA MOOPEN ASSUMED ROLE OF MANAGING DIRECTOR AND GROUP CEO

• ACQUISITION OF ASTER’S GCC BUSINESS WAS FINANCED THROUGH A MIX OF EQUITY AS WELL AS DEBT FROM REGIONAL FINANCIAL INSTITUTIONS

• DEBT FINANCING PACKAGE AGGREGATING $813 MILLION WAS PROVIDED ACROSS TWO SEPARATE FACILITIES

• A SHARIA COMPLIANT FACILITY TO ALPHA GCC HOLDINGS LIMITED, THE ACQUISITION VEHICLE TO FACILITATE THE ACQUISITION AS WELL AS SUPPORT FUTURE GROWTH PROSPECTS OF ASTER GCC

• A CONVENTIONAL FACILITY TO UNION (MAURITIUS) HOLDINGS LIMITED, THE ACQUISITION VEHICLE OF DR. MOOPEN’S FAMILY TO BRIDGE FINANCE ACQUISITION OF 35% IN ASTER GCC

• FINANCING PACKAGE FOR BOTH FACILITIES WAS PROVIDED BY CBD, EMIRATES NBD CAPITAL LIMITED, FAB AND MASHREQ ACTING AS MANDATED LEAD ARRANGERS, BOOKRUNNERS AND UNDERWRITERS WITH MASHREQ ACTING AS THE SOLE COORDINATOR FOR BOTH FACILITIES

• FOR ENBD GROUP, WHILE EMIRATES NBD CAPITAL LIMITED ACTED AS MANDATED LEAD ARRANGER, BOOKRUNNER AND UNDERWRITER, EMIRATES ISLAMIC BANK P.J.S.C. PROVIDED FINANCING IN SHARIA COMPLIANT FACILITY AND EMIRATES NBD BANK (P.J.S.C.) FINANCED THE CONVENTIONAL FACILITY

Further company coverage: MASB.DU

(([email protected];))

** Shares of Aster DM Healthcare ATRD.NS rise as much as 11.8%, last up 7.9%

** On track for steepest intraday gain since Nov.

** The healthcare services provider said it plans to add 1700 beds by FY27, with projects in Indian states of Kerala, Maharashtra, Uttar Pradesh

** Adds expansion cost in range of 10 bln rupees ($119.9 mln)

** Stock has been trading above its 200-day simple moving avg since Feb. 2023, volumes at 5.7 times the 30-day avg

** Analysts' avg rating on co is "Buy", their median PT is 480 rupees- a ~15% premium on last close

** Including session's gains, stock up ~10% this year

($1 = 83.4355 Indian rupees)

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

April 3 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• ASTER DM HEALTHCARE, INDIA TO FOCUS ON GREENFIELD AND BROWNFIELD EXPANSIONS IN NEXT 3 YEARS

• COMPANY PLANS TO ADD 1700 BEDS BY FY27 THROUGH ORGANIC ROUTE

• WILL FURTHER LOOK FOR EXPANSION THROUGH INORGANIC ROUTE AS WELL

Source text for Eikon: ID:nBSEbzvyhC

Further company coverage: ATRD.NS

(([email protected];))

** Shares of Aster DM HealthcareATRD.NS fall as much as 6.9% to 407 rupees, hitting their lowest level since Jan. 15

** PE firm Olympus plans to sell 9.8% stake worth $235 mln in the hospital chain, according to a term sheet seen by Reuters

** Stake sale planned in range of 400-437.20 rupees apiece, with the lower end representing 8.5% discount to ATRD's Tuesday close

** Nearly 1.8 mln shares of ATRD change hands in six block deals on Wednesday between 410.1 rupees to 415.15 rupees per share - LSEG data

** ATRD set for worst day of the year so far if trend holds

** Stock sees most active session of 2024, with more than 5.4 mln shares traded as of 9:45 a.m. IST

** Session's losses nearly erase YTD gains, stock up ~0.5% in 2024

(Reporitng by Nishit Navin)

(([email protected];))

Adds deal details, background of Aster DM expansion plan

By M. Sriram and Dimpal Gulwani

March 26 (Reuters) - Private equity firm Olympus Capital Asia plans to sell a 9.8% stake in India's Aster DM Healthcare ATRD.NS for up to 19.53 billion rupees (nearly $235 million), according to a term sheet seen by Reuters on Tuesday.

Olympus Capital, which owns about 19% stake in the hospital chain, is planning the sale at 400-437.20 rupees per share. The low end of the range represents an 8.5% discount to the Aster DM stock's last close and no discount at the upper range.

Aster DM and Olympus did not immediately respond to Reuters' requests for comment.

Reuters had reported in May that investors in Aster DM are in talks to sell a 30% stake in the company's India business for about $300 million, with Olympus Capital pegged to be one of the shareholders considering a stake sale.

Kotak Securities will act as the sole bookrunner for the stake sale, according to the term sheet.

Shares of the company, which runs 34 hospitals, 130 clinics and 508 pharmacies in India and the Gulf Cooperation Council, closed down 0.3% at 437.20 rupees on Tuesday. They have gained about 6.7% so far this year.

Last week, Aster DM said it plans to spend about $108 million to expand domestically, as it also nears completion of selling its Gulf business.

($1 = 83.2970 Indian rupees)

(Reporting by Sriram Mani and Dimpal Gulwani; Editing by Savio D'Souza, Eileen Soreng and Maju Samuel)

(([email protected];))

BENGALURU, March 20 (Reuters) - Hospital chain Aster DM Healthcare ATRD.NS on Wednesday said that the separation of its Indian and Gulf businesses, alongside the proposed investment in its GCC business by an investor group, is in the final stage of completion.

Aster DM Healthcare in November last year had agreed to sell a majority stake in its Gulf business to a consortium led by private-equity firm Fajr Capital for $1 billion.

(Reporting by Ashish Chandra in Bengaluru; Editing by Dhanya Ann Thoppil)

(([email protected]; +91 7982114624;))

BENGALURU, Feb 8 (Reuters) - Aster DM Healthcare ATRD.NS posted its first increase in quarterly profit since the first quarter of fiscal 2023 on the back of strong performance at the company's domestic hospitals segment.

Consolidated net profit for the third quarter rose 28.6% to 1.79 billion rupees ($21.6 million), the company said on Thursday.

While Aster's India business accounts for roughly a quarter of its revenue and Gulf Cooperation Council countries the rest, the company has focussed on expanding within India.

In November, the company agreed to sell a majority stake in its Gulf business for $1 billion to an investor group.

Aster's India revenue rose 23% in the third quarter ending Dec. 31, while Gulf revenue increased 14%.

An increase in the number of surgical procedures in the latter half of 2023 has benefited Aster, as well as rivals Apollo Hospitals APLH.NS and Max Healthcare MAXE.NS, despite October to December being a seasonally weak period for hospitals with fewer people scheduling health-related appointments.

Revenue from Aster's hospital segment, which accounts for more than half of the company's revenue, climbed almost 18% in the quarter.

Its clinics and retail pharmacies units also recorded revenue increases of 18% and 12%, respectively. The company's third-quarter total revenue rose 16% to 37.11 billion rupees.

Aster had reported a loss in the second quarter, which was preceded by four straight quarters when the company reported a lower profit.

Losses in new hospitals, including Aster Royal Hospital Muscat and Aster Narayanadri Tirupati, had hurt the company during the second quarter ended September.

Max Healthcare reported a rise in third-quarter profit as it earned higher revenue per bed, while Apollo Hospitals also beat profit estimates.

($1 = 82.9700 Indian rupees)

(Reporting by Varun Vyas in Bengaluru; Editing by Shounak Dasgupta)

(([email protected]))

Feb 6 (Reuters) - Aster DM Healthcare Ltd ATRD.NS:

• ASTER DM HEALTHCARE LTD - MALABAR INSTITUTE OF MEDICAL SCIENCES TO ACQUIRE 26% STAKE IN USOLAR ASSETCO TWO

• ASTER DM HEALTHCARE LTD - DEAL FOR 40 MILLION RUPEES

Source text for Eikon: ID:nBSE5JyVnj

Further company coverage: ATRD.NS

(([email protected];;))